November 06, 2025 /SemiMedia/ — Nexperia B.V. has provided an update on its global operations, corporate governance, and supply chain, highlighting recent developments affecting production and wafer delivery.

The temporary one-year suspension of the U.S. “Affiliate Rule” reduces export control implications for the company. China has also indicated support for resuming exports from Nexperia’s Chinese facility and subcontractors, enabling continued supply of key chips to international markets. Detailed procedures and conditions for this resumption are still pending.

Operations at the Chinese facility have exhibited deviations from established governance frameworks, resulting in limited transparency regarding production and delivery schedules. In late October 2025, Nexperia suspended direct wafer shipments to the Chinese facility while evaluating alternative supply chain arrangements to maintain product availability.

All other Nexperia production sites, including those in Europe and Asia, continue to operate normally. Products manufactured outside China comply with standard specifications, manufacturing processes, quality systems, and intellectual property requirements, and continue to be delivered to customers.

Corporate governance decisions, including the management of voting rights previously held by Wingtech, have been placed under an independent administrator by the Enterprise Chamber in the Netherlands. Nexperia continues to comply with Dutch government directives that safeguard European production capacity while requiring approval for certain strategic decisions.

For the original announcement, please refer to the official release: https://www.nexperia.com/about/news-events/press-releases/update-on-company-developments-2.